This study aimed to analyze the effect of fall risk-increasing drugs (FRIDs) and drug-related factors relative to falls through clinical pharmacy service in hospitalized patients, focusing on the relevance of clinical pharmacist evaluation in the context of physician assessment. A prospective study of inpatient falls was conducted in 2017 retrieving data from 4 hospitals in South Bohemia, Czech Republic. An online database was developed to collect patient and fall-related data, and fall evaluation records. Healthcare professionals classified the overall effect of drugs on falls using Likert scale. Univariate and multivariate correlations were performed with a significance level of p < 0.05. Out of the total 280 falls (mean age of patients 77.0 years), a mean of 2.8 diagnoses with fall-related risk, 8.8 drugs, and 4.1 FRIDs per fall were identified. Incidence of falls decreased quarterly (p < 0.001). Use of FRIDs were positively associated with increasing age (p = 0.007). Clinical pharmacists were more likely to identify pharmacotherapy as the relevant fall-related risk, compared to physicians evaluation (p < 0.001). An increasing total number of prescribed drugs as well as higher number of FRIDs increased the suspicion in both professionals in the context of drug-related causes of falls.

Charles University Faculty of Pharmacy in Hradec Kralove Department of Social and Clinical Pharmacy Hradec Kralove Czech Republic

University of South Bohemia in Ceske Budejovice Faculty of Health and Social Sciences Institute of Nursing Midwifery and Emergency Care Ceske Budejovice Czech Republic

Zobrazit více v PubMed

Bartlett D, Pang N, Massey C, Evans P (2015). Pharmacist consultations: simplifying daily drug regimens and providing education on fall risk for older adults. Consult Pharm 30(3): 141-152. DOI: 10.4140/TCP.n.2015.141. PubMed DOI

Beasley B, Patatanian E (2009). Development and implementation of a pharmacy fall prevention program. Hosp Pharm 44(12): 1095-1102. DOI: 10.1310/hpj4412-1095. DOI

Bloch F, Thibaud M, Tournoux-Facon C, Brèque C, Rigaud AS, Dugué B, Kemoun G (2013). Estimation of the risk factors for falls in the elderly: can meta-analysis provide a valid answer? Geriatr Gerontol Int 13(2): 250-263. DOI: 10.1111/j.1447-0594.2012.00965.x. PubMed DOI

Browne C, Kingston C, Keane C (2014). Falls prevention focused medication review by a pharmacist in an acute hospital: implications for future practice. Int J Clin Pharm 36(5): 969-975. DOI: 10.1007/s11096-014-9980-3. PubMed DOI

Caffiero N, Delate T, Ehizuelen MD, Vogel K (2017). Effectiveness of a clinical pharmacist medication therapy management program in discontinuation of drugs to avoid in the elderly. J Manag Care Spec Pharm 23(5): 525-531. DOI: 10.18553/jmcp.2017.23.5.525. PubMed DOI

Cheema E, Alhomoud FK, Kinsara ASA, Alsiddik J, Barnawi MH, Al-Muwallad MA, et al. (2018). The impact of pharmacists-led medicines reconciliation on healthcare outcomes in secondary care: A systematic review and meta-analysis of randomized controlled trials. PLoS One 13(3): e0193510. DOI: 10.1371/journal.pone.0193510. PubMed DOI

Chen Y, Zhu LL, Zhou Q (2014). Effects of drug pharmacokinetic/pharmacodynamic properties, characteristics of medication use, and relevant pharmacological interventions on fall risk in elderly patients. Ther Clin Risk Manag 10: 437-448. DOI: 10.2147/TCRM.S63756. PubMed DOI

de Jong MR, Van der Elst M, Hartholt KA (2013). Drug-related falls in older patients: implicated drugs, consequences, and possible prevention strategies. Ther Adv Drug Saf 4(4): 147-154. DOI: 10.1177/2042098613486829. PubMed DOI

de Vries M, Seppala LJ, Daams JG, van de Glind EMM, Masud T, van der Velde N, EUGMS Task and Finish Group on Fall-Risk-Increasing Drugs (2018). Fall-risk-increasing drugs: a systematic review and meta-analysis: I. cardiovascular drugs. J Am Med Dir Assoc 19(4): 371.e1-371.e9. DOI: 10.1016/j.jamda.2017.12.013. PubMed DOI

Deandrea S, Lucenteforte E, Bravi F, Foschi R, La Vecchia C, Negri E (2010). Risk factors for falls in community-dwelling older people: a systematic review and meta-analysis. Epidemiology 21(5): 658-668. DOI: 10.1097/EDE.0b013e3181e89905. PubMed DOI

Glab KL, Wooding FG, Tuiskula KA (2014). Medication-related falls in the elderly: mechanisms and prevention strategies. Consult Pharm 29(6): 413-417. DOI: 10.4140/TCP.n.2014.413. PubMed DOI

Hajduchová H, Brabcová I, Tóthová V, Bártlová S (2016). Retrospective analysis of falls in selected hospitals of the Czech Republic. Neuro Endocrinol Lett 37(Suppl. 2): 18-24.

Hunderfund ANL, Sweeney CM, Mandrekar JN, Johnson LM, Britton JW (2011). Effect of a multidisciplinary fall risk assessment on falls among neurology inpatients. Mayo Clin Proc 86(1): 19-24. DOI: 10.4065/mcp.2010.0441. PubMed DOI

IBM Micromedex® (2018) - electronic version. Truven health analytics, Greenwood Village, Colorado, USA. [online] [cit. 2018-07-20]. Available from: http://www.micromedexsolutions.com/

Institute of Health Information and Statistics of the Czech Republic (2018). National database of adverse events. [online] [cit. 2018-07-15]. Available from: http://shnu.uzis.cz/index.php

Jung D, Shin S, Kim H (2014). A fall prevention guideline for older adults living in long-term care facilities. Int Nurs Rev 61(4): 525-533. DOI: 10.1111/inr.12131. PubMed DOI

Krnacova V, Kubena A, Macek K, Bezdek M, Smahelova A, Vlcek J (2012). Severe hypoglycaemia requiring the assistance of emergency medical services - frequency, causes and symptoms. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 156(3): 271-277. DOI: 10.5507/bp.2012.037. PubMed DOI

Lord SR, Sherrington C, Menz HB, Close JCT (2011). Falls in older people. Risk factors and strategies for prevention, 2nd ed. Cambridge: University Press.

Lovallo C, Rolandi S, Rossetti AM, Lusignani M (2010). Accidental falls in hospital inpatients: evaluation of sensitivity and specificity of two risk assessment tools. J Adv Nurs 66(3): 690-696. DOI: 10.1111/j.1365-2648.2009.05231.x. PubMed DOI

Mackin P (2008). Cardiac side effects of psychiatric drugs. Hum Psychopharmacol 23(Suppl 1): 3-14. DOI: 10.1002/hup.915. PubMed DOI

Marvin V, Ward E, Poots AJ, Heard K, Rajagopalan A, Jubraj B (2017). Deprescribing medicines in the acute setting to reduce the risk of falls. Eur J Hosp Pharm 24(1): 10-15. DOI: 10.1136/ejhpharm-2016-001003. PubMed DOI

Miake-Lye IM, Hempel S, Ganz DA, Shekelle PG (2013). Inpatient fall prevention programs as a patient safety strategy: a systematic review. Ann Intern Med 158(5 Pt 2): 390-396. DOI: 10.7326/0003-4819-158-5-201303051-00005. PubMed DOI

Milos V, Bondesson Å, Magnusson M, Jakobsson U, Westerlund T, Midlöv P (2014). Fall risk-increasing drugs and falls: a cross-sectional study among elderly patients in primary care. BMC Geriatr 14: 40. DOI: 10.1186/1471-2318-14-40. PubMed DOI

Mott DA, Martin B, Breslow R, Michaels B, Kirchner J, Mahoney J, Margolis A (2016). Impact of a medication therapy management intervention targeting medications associated with falling

Results of a pilot study. J Am Pharm Assoc (2003). 56(1): 22-28. DOI: 10.1016/j.japh.2015.11.001. PubMed DOI

Okada K, Okada M, Kamada N, Yamaguchi Y, Kakehashi M, Sasaki H, et al. (2017). Reduction of diuretics and analysis of water and muscle volumes to prevent falls and fall-related fractures in older adults. Geriatr Gerontol Int 17(2): 262-269. DOI: 10.1111/ggi.12719. PubMed DOI

Ribeiro TB, de Melo DO, Maia FDM, Ribeiro E (2018). Medication-related inpatient falls: a critical review. Braz J Pharm Sci 54(1): e17355. DOI: 10.1590/s2175-97902018000117355. DOI

Seppala LJ, Wermelink AMAT, de Vries M, Ploegmakers KJ, van de Glind EMM, Daams JG, et al. (2018a). Fall-Risk-Increasing Drugs: A Systematic Review and Meta-analysis: II. Psychotropics. J Am Med Dir Assoc 19(4): 371.e11-371.e17. DOI: 10.1016/j.jamda.2017.12.098. PubMed DOI

Seppala LJ, van de Glind EMM, Daams JG, Ploegmakers KJ, de Vries M, Wermelink, AMAT, et al. (2018b). Fall-risk-increasing drugs: a systematic review and meta-analysis: III. Others. J Am Med Dir Assoc 19(4): 372.e1-372.e8. DOI: 10.1016/j.jamda.2017.12.099. PubMed DOI

Söderberg KC, Laflamme L, Möller J (2013). Newly initiated opioid treatment and the risk of fall-related injuries. A nationwide, register-based, case-crossover study in Sweden. CNS Drugs 27(2): 155-161. DOI: 10.1007/s40263-013-0038-1. PubMed DOI

Walker R, Whittlesea C (2012). Clinical pharmacy and therapeutics. Edinburgh: Churchill Livingstone.

Weddle SC, Rowe AS, Jeter JW, Renwick RC, Chamberlin SM, Franks AS (2017). Assessment of clinical pharmacy interventions to reduce outpatient use of high-risk medications in the elderly. J Manag Care Spec Pharm 23(5): 520-524. DOI: 10.18553/jmcp.2017.23.5.520. PubMed DOI

World Health Organization (2018). Falls. [online] [cit. 2018-07-10]. Available from: http://www.who.int/news-room/fact-sheets/detail/falls

Zia A, Kamaruzzaman SB, Tan MP (2017). The consumption of two or more fall risk-increasing drugs rather than polypharmacy is associated with falls. Geriatr Gerontol Int 17(3): 463-470. DOI: 10.1111/ggi.12741. PubMed DOI

Fig. 1. Different opinions on drugs as fall-related causesAryee E, James SL, Hunt GM, Ryder HF (2017). Identifying protective and risk factors for injurious falls in patients hospitalized for acute care: a retrospective case-control study. BMC Geriatr 17: 260. DOI: 10.1186/s12877-017-0627-9. PubMed DOI

Fig. 1. Different opinions on drugs as fall-related causesAryee E, James SL, Hunt GM, Ryder HF (2017). Identifying protective and risk factors for injurious falls in patients hospitalized for acute care: a retrospective case-control study. BMC Geriatr 17: 260. DOI: 10.1186/s12877-017-0627-9. PubMed DOI

Inclusion of medication-related fall risk in fall risk assessment tool in geriatric care units